Skip to main content
Meihua Holdings Group Co.,Ltd logo

Meihua Holdings Group Co.,Ltd — Investor Relations & Filings

Ticker · 600873 ISIN · CNE000000HP9 LEI · 300300T0DPJPWDP2WE30 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,070 across all filing types
Latest filing 2026-05-28 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600873

About Meihua Holdings Group Co.,Ltd

https://www.meihua.group/

Meihua Holdings Group Co., Ltd. is a global manufacturer specializing in biological fermentation and the large-scale production of amino acids. The company operates an integrated industrial chain focused on the research, development, and manufacturing of high-quality biochemical products. Its primary portfolio includes food additives such as monosodium glutamate (MSG), animal nutrition products like lysine, threonine, and tryptophan, and various pharmaceutical-grade amino acids. Additionally, the company produces xanthan gum and organic fertilizers as part of its resource recycling initiatives. Meihua Holdings serves a diverse international clientele across the food processing, animal husbandry, and pharmaceutical sectors, leveraging advanced biotechnology and cost-efficient production processes to maintain a competitive position in the global biochemical market.

Recent filings

Filing Released Lang Actions
梅花生物2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is an official announcement of the resolutions and voting results of the 2025 Annual General Meeting (AGM). It lists meeting details, agendas considered, and precise vote counts and percentages for each proposal, along with legal witness statements. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-28 Chinese
北京市君合律师事务所关于梅花生物科技集团股份有限公司2025年年度股东会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a legal opinion letter by the company’s law firm addressing the legality of convening, attendance, voting procedures and it extensively lists the voting results for each AGM resolution. This fits the category of ‘Declaration of Voting Results & Voting Rights Announcements’ (DVA), which covers official results from shareholder votes at any general meeting.
2026-05-28 Chinese
梅花生物2025年年度股东会会议资料
AGM Information Classification · 96% confidence The document is titled “2025年年度股东会会议资料” and contains the AGM notice, meeting agenda, proposals for shareholder votes, and materials to be presented at the 2025 Annual General Meeting (股东会). It is not the standalone annual report but the meeting materials distributed for the AGM, matching the AGM Information category.
2026-05-22 Chinese
梅花生物关于2026年员工持股计划完成股票购买的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of stock purchases under the company's 2026 employee stock ownership plan. It details the purchase price, number of shares bought, percentage of total shares, and subsequent lock-up arrangements. The document is relatively short (1146 characters) and serves as a formal disclosure of the transaction completion rather than a detailed report or financial statement. It does not contain financial results, management discussion, or regulatory certifications. This fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure about employee stock plan implementation and share purchases, not a full report or a capital/financing update announcement per se.
2026-04-23 Chinese
梅花生物关于股份回购实施结果暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement about the implementation results of a share repurchase program by the company 梅花生物科技集团股份有限公司. It includes specifics such as the number of shares repurchased, the price range, the total amount spent, the purpose of the repurchase, and the impact on share capital. It also discusses the approval process, the timeline, and related insider transactions during the repurchase period. The document is not a financial report, earnings release, or management discussion, but rather a formal disclosure of the company's share buyback activity. This fits the definition of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length and content confirm it is the actual announcement of the repurchase results, not just a brief notice or a regulatory filing. Therefore, the correct classification is POS with high confidence.
2026-04-23 Chinese
梅花生物2026年度董事、高级管理人员薪酬方案（草案）
Remuneration Information Classification · 95% confidence The document is titled '董事、高级管理人员薪酬方案（草案）' which translates to 'Draft Remuneration Plan for Directors and Senior Management'. It details the remuneration structure, performance evaluation, and incentive schemes for the company's directors and senior management for the year 2026. The content focuses exclusively on compensation policies and plans for executives rather than financial results, governance structure, or other corporate activities. It is not a full annual report, audit report, or earnings release. It is not an announcement or proxy solicitation but a detailed remuneration plan document. Therefore, it fits the definition of a Remuneration Information filing, which reports compensation for top executives and directors.
2026-04-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.